Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Aryl Quinazoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557737B details a high-yield Pd-catalyzed route for quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104557737A reveals high-yield Pd-catalyzed route. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN106632086B details a Rhodium-catalyzed C-H iodination method for quinazolines. This process offers high purity, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.